OMEPRAZOLE EXTENDED
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded Contract SPE2DP26F4285 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, under the parent delivery order SPE2DX25D9900, with an award date of April 8, 2026. The contract is for the supply of OMEPRAZOLE EXTENDED, identified by NSN 6505013142716, though the total contract price is specified to be found in the official award documentation. This procurement is part of a federal acquisition effort managed by the Department of Defense, with no set-aside classification indicated. The place of performance and specific office address details are not provided, but the procurement is conducted under U.S. federal authority. The solicitation was posted on the DIBBS system on July 23, 2026, and the official record can be accessed via the provided DIBBS link for further details on delivery and performance expectations.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(3)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
